Danimer Scientific, Inc.
DNMR · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $4,161,674 | $7,238,426 | $31,720,984 | $79,497,316 |
| - Cash | $59,170 | $62,792 | $286,487 | $377,581 |
| + Debt | $408,068 | $313,821 | $287,321 | $83,762 |
| Enterprise Value | $4,510,572 | $7,489,455 | $31,721,818 | $79,203,497 |
| Revenue | $46,684 | $53,218 | $58,749 | $47,333 |
| % Growth | -12.3% | -9.4% | 24.1% | – |
| Gross Profit | -$26,960 | -$7,908 | $884 | $11,457 |
| % Margin | -57.7% | -14.9% | 1.5% | 24.2% |
| EBITDA | -$96,127 | -$103,489 | -$87,716 | -$1,817 |
| % Margin | -205.9% | -194.5% | -149.3% | -3.8% |
| Net Income | -$155,473 | -$179,758 | -$60,107 | -$8,853 |
| % Margin | -333% | -337.8% | -102.3% | -18.7% |
| EPS Diluted | -1.52 | -1.78 | -0.65 | -0.1 |
| % Growth | 14.6% | -173.8% | -550% | – |
| Operating Cash Flow | -$47,264 | -$61,837 | -$62,963 | -$13,797 |
| Capital Expenditures | -$27,685 | -$164,486 | -$185,411 | -$38,268 |
| Free Cash Flow | -$74,949 | -$226,323 | -$248,374 | -$52,065 |